Toronto Dominion Bank Fsd Pharma Inc. Transaction History

Toronto Dominion Bank

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Feb 14, 2024	SELL	$1.07 - $1.6 $70 - $105	-66 Reduced 86.84%	10 $0
Q3 2023 Nov 14, 2023	SELL	$1.07 - $1.6 $70 - $105	-66 Reduced 86.84%	10 $0
Q2 2023 Feb 14, 2024	BUY	$0.99 - $2.04 $75 - $155	76 New	76 $0
Q2 2023 Aug 10, 2023	BUY	$0.99 - $2.04 $6 - $14	7 Added 10.14%	76 $0
Q1 2023 May 11, 2023	BUY	$0.77 - $1.81 $53 - $124	69 New	69 $0

Q2 2022 Aug 11, 2022	BUY	$0.78 - $1.1 $174 - $246	224 Added 311.11%	296 $0
Q1 2022 May 09, 2022	BUY	$0.82 - $1.1 $59 - $79	72 New	72 $0
Q4 2021 Feb 04, 2022	SELL	$0.96 - $1.63 $92 - $156	-96 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$1.45 - $1.84 $298 - $379	-206 Reduced 68.21%	96 $0
Q2 2021 Aug 13, 2021	BUY	$1.56 - $2.13 $471 - $643	302 New	302 $1,000

Ticker HUGE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 38,218,100
Market Cap $5.73M
Description
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.